The Role of Tuberculosis in Chronic Obstructive Lung Disease
NCT ID: NCT02759848
Last Updated: 2016-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
598 participants
OBSERVATIONAL
2012-01-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary Tuberculosis Sequelae in Patients With COPD
NCT04721080
Cross-sectional Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities
NCT01325948
The Clinical Characteristics, Treatment and Prognosis of Tuberculosis-associated COPD
NCT06074042
Clinical Features of Smoker Patients With Chronic Obstructive Pulmonary Disease
NCT04711629
Bronchiectasis Effect in COPD Patients
NCT03670940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our results showed that past TB caused more hospitalizations, lower respiratory functions and higher arterial carbon dioxide levels. It was found that, though the mortality rates were similar, COPD patients with past TB was diagnosed and died five-year earlier. We conclude that history of TB has an important role in natural course of COPD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
with history of TB
No interventions assigned to this group
without history of TB
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medeniyet University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Halil İbrahim Yakar
Halil İbrahim Yakar
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Halil I Yakar, Md
Role: PRINCIPAL_INVESTIGATOR
Halil Ibrahim Yakar
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TROTIC-1234-TROTIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.